RHHBY - Gene editors steady despite latest leadership shake-up at FDA
2025-06-20 08:39:22 ET
More on Editas Medicine
- Editas Medicine, Inc. (EDIT) BofA Securities 2025 Healthcare Conference (Transcript)
- Editas Medicine: Do The Risks Outweigh The Rewards?
- RFK Jr. looks to fast track rare disease drug approvals (updated)
- Editas Medicine, Cassava Sciences among healthcare stocks to join Russell Microcap; MNKD, OCGN to exit
- Seeking Alpha’s Quant Rating on Editas Medicine